Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varespladib in Patients Hospitalized With Severe COVID-19
NCT04969991Phase 2Terminated
- Sponsor
- Ophirex
- Start
- Jun 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of varespladib in coronavirus disease 2019 (COVID-19), sponsored by Ophirex. Started Jun 2021; status: terminated.
02
Drugs
varespladib
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04969991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04969991.